Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001583 |
---|---|
Receipt number | R000001771 |
Scientific Title | Feasibility study of adjuvant chemotherapy consisting of FEC(fluoraouracil, epirubicin and cyclophosphamide) followed by DH(docetaxel+herceptin) for patients with HER2 positive breast cancer |
Date of disclosure of the study information | 2008/12/17 |
Last modified on | 2018/05/14 16:40:19 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/12/17 08:34:13 | ||
2 | Update | 2008/12/19 14:22:45 | Public title Acronym |
|
3 | Update | 2008/12/19 14:27:52 | Narrative objectives1 Primary outcomes Key secondary outcomes |
|
4 | Update | 2008/12/19 14:39:16 | Interventions/Control_1 Key inclusion criteria Key exclusion criteria |
|
5 | Update | 2010/06/17 09:49:33 | Recruitment status |
|
6 | Update | 2010/08/04 15:20:19 | Recruitment status |
|
7 | Update | 2010/08/04 15:21:55 | Division name Address |
|
8 | Update | 2011/07/26 11:24:14 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
9 | Update | 2018/05/14 16:40:19 | Email Address Address TEL Name of primary person or sponsor Organization |